Skip to main content
C
CorpDigest
Search

CVS Health Corp.

Healthcare / Pharmacy RetailFounded 1963
Reviewed by Swet Parvadiya
Company data updated: October 2026

Leadership History

CVS Health: CEO History

4 leaders · 1998 to present

Who is the CEO of CVS Health?

David Joyner is the CEO of CVS Health, in the role since 2024. The first chief executive was Thomas Ryan, from 1998.

Current CEO
David Joyner (since 2024)
First CEO
Thomas Ryan (1998)
Leaders documented
4
Founded
1963
NameRoleFromToYears in role
David JoynerChairman, President and Chief Executive Officer2024Present2
Karen LynchPresident and Chief Executive Officer202120243
Larry MerloPresident and Chief Executive Officer2011202110
Thomas RyanPresident and Chief Executive Officer1998201113
Who was CEO of CVS Health before David Joyner?
Karen Lynch was CEO of CVS Health from 2021 to 2024, before David Joyner took over in 2024.

Company Overview

CVS Health is a Woonsocket, Rhode Island-based health care company and one of the largest U.S. companies by revenue. Most consumers know it as the CVS Pharmacy on the corner, but the retail store is only one of three businesses. CVS also owns Aetna, one of the largest U.S. health insurers, and CVS Caremark, one of the three largest pharmacy benefit managers. Together with Oak Street Health clinics, Signify Health in-home visits, and MinuteClinic, the company connects with roughly 185 million consumers. The massive American healthcare conglomerate was founded in Lowell, Massachusetts in 1963, originally starting as a simple discount health and beauty store before executing massive, multi-billion-dollar mega-mergers to completely dominate every layer of the US healthcare system.

David Joyner

Chairman, President and Chief Executive Officer

2024 – Present

2 years (current)

Legacy

A longtime pharmacy benefits executive who led CVS Caremark before succeeding Karen Lynch as CEO in October 2024, Joyner has focused on execution over acquisitions: repricing Aetna's Medicare Advantage business, moving CVS Pharmacy to cost-based reimbursement, exiting Omnicare and the ACA exchange market, and replacing much of the senior team, including CFO Brian Newman. He became Chairman in January 2026, and CVS raised 2026 guidance as earnings recovered.

Source →

Karen Lynch

President and Chief Executive Officer

2021 – 2024

3 years

Legacy

Led CVS through Oak Street Health and other care-delivery acquisitions, but departed during the 2024 Medicare Advantage underwriting crisis. Lynch, a Boston College and Boston University graduate who began her career as a CPA at Ernst & Young, became the first female president of Aetna in 2015 before CVS acquired Aetna in 2018. She became CVS Health CEO in February 2021, at the time the highest-ranking female CEO on the Fortune 500, and led the company until October 2024. During her tenure, CVS faced significant margin pressure in its Medicare Advantage insurance business due to higher-than-expected medical costs, a challenge that contributed to her departure and the board's decision to bring in Joyner's operational expertise. Before becoming CVS Health CEO, she also served as executive vice president of CVS Health starting in 2018, overseeing the integration of Aetna following its acquisition, giving her direct experience with the health-insurance business before leading the combined company. She also oversaw the continued rollout of CVS HealthHubs, in-store clinics offering expanded health services beyond traditional pharmacy counters, part of the company's broader strategy to position retail locations as primary-care access points.

Source →

Larry Merlo

President and Chief Executive Officer

2011 – 2021

10 years

Legacy

Led the Aetna acquisition and the 2014 removal of tobacco products as CVS repositioned itself as a health company. Merlo, a University of Pittsburgh pharmacy graduate, joined CVS in 1990 when it acquired his employer Peoples Drug, rising through store operations and pharmacy leadership before becoming CEO in March 2011. He led the company for nearly a decade, including its transformative 2018 acquisition of Aetna, before retiring in January 2021. He also oversaw CVS's controversial 2014 decision to stop selling tobacco products in its stores, forgoing an estimated $2 billion in annual revenue in a move the company framed as consistent with its healthcare-focused brand identity. Merlo also led CVS through its 2015 acquisition of Omnicare, a long-term-care pharmacy provider, and the 2015 acquisition of Target's pharmacy and clinic business, continuing the company's expansion beyond retail pharmacy into broader healthcare services during his decade as CEO. He retired from CVS in early 2021.

Source →

Thomas Ryan

President and Chief Executive Officer

1998 – 2011

13 years

Legacy

Oversaw national pharmacy expansion, the 1997 Revco deal, and the 2007 Caremark merger that created the PBM core of CVS Health. A University of Rhode Island pharmacy graduate who began his career as a CVS pharmacist, Ryan became CEO in 1998 and led the company until 2011.

Source →

Challenges & Strategic Context

Key risks include PBM reform and rebate transparency rules, Medicare Advantage and Part D cost trends, retail pharmacy reimbursement pressure, care delivery profitability after a $5.7B goodwill impairment in 2025, legacy opioid and Omnicare litigation, and regulatory scrutiny of combining an insurer, PBM, and pharmacy chain.

CVS Health CEO and Leadership FAQ

Who is David Joyner and what is his background as CEO of CVS Health?

David Joyner became President and CEO of CVS Health in October 2024 after leading CVS Caremark, and added the role of Chairman in January 2026. He is a longtime pharmacy benefits executive.

What strategic priorities did David Joyner announce upon taking leadership of CVS Health?

Upon becoming CEO in October 2024, David Joyner prioritized stabilizing Aetna's medical costs, optimizing Medicare Advantage underwriting, accelerating the integration of Oak Street Health and Signify Health, driving cost efficiencies, and restoring shareholder value.

Who was Karen S. Lynch and what were her achievements as CEO from 2021 to 2024?

Karen Lynch, previously president of Aetna, was CVS Health CEO from February 2021 to October 2024. She led the COVID-19 testing and vaccination effort and the Signify Health and Oak Street Health acquisitions, and left amid Aetna's Medicare Advantage losses.

Who was Larry J. Merlo and what was his transformative legacy as CEO from 2011 to 2021?

Larry J. Merlo served as CEO of CVS Health for a decade (2011 to 2021). Merlo transformed CVS from a traditional retail pharmacy chain into a healthcare giant: famously halting tobacco sales in 2014, rebranding the company to CVS Health, and orchestrating the historic $69 billion acquisition of Aetna in 2018.

Who was Tom Ryan and how did he build modern CVS in the 1990s and 2000s?

Tom Ryan, a pharmacist who began his career at CVS, served as CEO from 1998 to 2011 and led the 2007 merger with Caremark Rx that created CVS Caremark.

Who is CVS Health's Chief Financial Officer?

Brian Newman, former CFO of UPS, became CVS Health's Executive Vice President and CFO in May 2025, succeeding Tom Cowhey.

Who is the chairman of CVS Health?

CEO David Joyner became Chairman of the CVS Health Board in January 2026.

Who is the CEO of CVS Health?

Karen Lynch currently serves as CEO. A highly experienced healthcare executive who previously ran Aetna, she was brought in to seamlessly integrate the massive insurance business into CVS's retail footprint and expand their primary care offerings.

Related Leadership Timelines

Compare executive leadership tenures and strategic transitions

Competitor

Unitedhealth

View Leadership Timelines
Competitor

Cigna

View Leadership Timelines
Competitor

Walgreens Boots Alliance

View Leadership Timelines
Competitor

Humana

View Leadership Timelines
Competitor

Elevance Health

View Leadership Timelines
Competitor

Walmart

View Leadership Timelines

Explore CVS Health

Core profile pages, founders and related research hubs for this company.

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.